Thus, lower serum IL-6 level in LAG treatment, compared with OG treatment, was confirmed in our analysis, which is consistent with previous studies, suggesting that the choice of gastrectomy procedures should be carefully considered based on individual patient’s pathology and co-morbidity, to derive maximal outcomes for GC patients. Here, IL6 is linked to gastric cancer.